Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types And...
Pfizer Oncology will present new data across its portfolio representing novel approaches to researching treatments for patients with rare and difficult-to-treat cancers. These results will be presented...
View ArticleTriple-Negative Breast Cancer Responds Well To Cetuximab Addition To...
Women with metastatic triple-negative breast cancer respond twice as well to chemotherapy if Cetuximab is added, researchers revealed at the 35th Congress of the European Society for Medical Oncology...
View ArticleTransgenomic Develops New Assays To Detect EGFR Mutations Using COLD-PCR
Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced completion of a development study of several new assays to detect genetic mutations using the Company’s proprietary Co-amplification at Lower...
View ArticlePublication Of Survival Benefit In Leading Journal Emphasizes Importance Of...
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that an updated analysis of the Phase III CRYSTALa study has been published in the latest edition of the Journal of Clinical...
View ArticleSymphogen To Present Data From The First Clinical Trial With Sym004 At ASCO
Symphogen announced today that the company will present preliminary Phase 1 data evaluating the company’s lead cancer compound, Sym004, at the 2011 Annual Meeting of the American Society of Clinical...
View Article
